Bio Medica Laboratories IPO 2026: Healthcare and Pharmaceutical Manufacturer Plans Expansion Amid Rising Industry Demand
Bio Medica Laboratories IPO has attracted attention in the SME segment as the pharmaceutic...
Read ArticleBio Medica Laboratories IPO details, live grey market premium (GMP), dates, price band, lot size, subscription & review.
| IPO Open Date | 20 May 2026 | IPO Close Date | 24 May 2026 |
|---|---|---|---|
| Basis of Allotment | 25 May 2026 | Listing Date | 28 May 2026 |
| Price Band | ₹132 - ₹139 per share | Face Value | ₹10 per share |
| Market Lot Size | 1000 Shares | Min Investment (Retail) | ₹2,78,000 |
| Total Issue Size | ₹139 Cr | Issue Type | Book Built Issue IPO |
| Fresh Issue | — | Offer for Sale (OFS) | — |
| Listing At | NSE, BSE | Issue Category | SME Issue |
| Registrar | TBA | ||
| Event | Tentative Date | Status |
|---|---|---|
| IPO Open Date | 20 May 2026 | Confirmed |
| IPO Close Date | 24 May 2026 | Confirmed |
| Basis of Allotment | 25 May 2026 | Tentative |
| Initiation of Refunds | TBA | Tentative |
| Credit of Shares to Demat | TBA | Tentative |
| IPO Listing Date | 28 May 2026 | Tentative |
| Cut-off time for UPI Mandate Confirmation | 5:00 PM on Closing Day | Deadline |
* Note: Timelines are tentative and subject to regulatory confirmation. UPI mandate approvals must be completed by 5:00 PM on the IPO closing day.
| Application Category | Lots | Shares | Amount (at Cut-off) |
|---|---|---|---|
| Retail (Min) | 2 Lots | 2,000 Shares | ₹2,78,000 |
| Retail (Max) | 2 Lots | 2,000 Shares | ₹2,78,000 |
| S-HNI (Min) | 3 Lots | 3,000 Shares | ₹4,17,000 |
| S-HNI (Max) | 7 Lots | 7,000 Shares | ₹9,73,000 |
| B-HNI (Min) | 8 Lots | 8,000 Shares | ₹11,12,000 |
| Date | IPO GMP (₹) | Estimated Listing Price | Estimated Listing Gain (%) |
|---|---|---|---|
| 26 May 2026 | ₹0 | ₹139.00 | +0.00% |
| 25 May 2026 | ₹0 | ₹139.00 | +0.00% |
| Investor Category | Share Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 36,000 Shares | 50% |
| NII Shares Offered | 17,55,000 Shares | 15% |
| Retail Shares Offered | 17,92,000 Shares | 35% |
The Bio Medica Laboratories IPO date is May 21 and the close date is May 25. The Bio Medica Laboratories IPO allotment will be finalized on May 26 and the IPO listing on May 28.
| Event | Date |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Refunds | May 27, 2026 |
| Credit to Demat Account | May 27, 2026 |
| IPO Listing Date | May 28, 2026 |
| IPO Bidding Cut-off Time | May 25, 2026 – 5 PM |
| Particular | Dates |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Basis of Allotment | 26 May 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 29 May 2026 |
Note: The timeline for Bio Medica Laboratories IPO is tentative and subject to change.
| Purpose | Crores |
|---|---|
| Repayment of Loan | ₹7.25 |
| Enhancement of its Existing Production Capabilities by Setting Up of New Manufacturing Facility at the Existing Premises | ₹24.81 |
| General Corporate Purpose | ₹- |
To Be Updated Soon
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹16.25 | ₹15.80 | ₹0.33 | ₹17.57 |
| 2024 | ₹15.34 | ₹11.69 | ₹2.50 | ₹19.53 |
| 2025 | ₹38.33 | ₹25.18 | ₹9.79 | ₹39.12 |
| Nov 2025 | ₹28.63 | ₹16.95 | ₹8.66 | ₹65.17 |
To Be Updated Soon
To Be Updated Soon
To Be Updated Soon
Bio Medica Laboratories IPO opens for subscription on 20 May 2026 and closes on 24 May 2026.
The price band for Bio Medica Laboratories IPO is set at ₹132.00 to ₹139.00 per share.
The minimum market lot size is 1000 shares. A retail investor can apply for a minimum of 1 lot requiring an investment of 2,000 Shares (₹2,78,000).
The latest Grey Market Premium (GMP) for Bio Medica Laboratories IPO is ₹-27.80. GMP represents the unofficial premium at which shares trade prior to listing.
The basis of allotment for Bio Medica Laboratories IPO is tentatively scheduled for 25 May 2026, and shares are expected to list on the stock exchanges on 28 May 2026.
The registrar details will be confirmed in the official prospectus.